Latest News about PFE
Recent news which mentions PFE
Why Moderna Stock Dropped Today
September 19, 2022
From Motley Fool
Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?
September 19, 2022
From InvestorPlace
‘Reshoring’ is poised to boost U.S. companies bringing business back home. Shares of these 17 companies will benefit.
September 19, 2022
From MarketWatch
2 Biotech Stocks You Can Buy and Hold for the Next Decade
September 19, 2022
From Motley Fool
Moderna Provides Vaccine For Preclinical Studies As WHO Tries Developing Its Own COVID-19 Shot: Report
September 19, 2022
From Benzinga
2 Good-News Stocks on a Frightful Friday
September 16, 2022
From Motley Fool
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
From Benzinga
Europe may give COVID vaccines full marketing authorization to avoid annual review, and WHO backs Gilead’s Veklury for severe disease
September 16, 2022
From MarketWatch
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
From Benzinga
Pfizer's Pentavalent Meningococcal Vaccine Candidate Shows Efficacy In Adolescents
September 15, 2022
From Benzinga
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
From Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
From Benzinga
Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine
September 14, 2022
From Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
From Benzinga
4 Dividend Stocks Set to Hike Payouts in 2023
September 13, 2022
From InvestorPlace
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
September 12, 2022
From Benzinga
From InvestorPlace
Want Passive Income? Buy These 2 Beaten-Down Dividend Stocks
September 10, 2022
From Motley Fool
Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary
September 09, 2022
From Benzinga
This Troubling News Could Put a Dent in Pfizer's Sales
September 09, 2022
Tickers
PFE
From Motley Fool
Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay
September 09, 2022
From Benzinga
U.S. FDA And European Medicines Agency Accepted Pfizer's Hair Loss Candidate Submission For Review
September 09, 2022
Tickers
PFE
From Benzinga
Here's Why These Top 3 COVID-19 Vaccine Stocks Broke Down in August
September 08, 2022
From Motley Fool
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 07, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.